Clinical Trial Update: Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients [NA]

View source ↗

Summary

This clinical trial update describes ongoing research on optimal antibiotic duration and outcomes in high-risk febrile neutropenia patients, focusing on bloodst…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia Due to Gram-negative Bacteria
• Bloodstream Infection
• Febrile Neutropenia
• Gram-negative Bacterial Infections

Snippet

Sponsor: Humanitas University | Conditions: Bloodstream Infection, Gram Negative Infections | NA | Status: RECRUITING